A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered In Combination With Induction And Consolidation Chemotherapy And Administered As Maintenance Therapy In Adult Patients With Newly Diagnosed Flt3-Itd Negative Acute Myeloid Leukemia (QuaNTUM-Wild)

Principal Investigator

Connor Sweeney

Contact us

Email: Latephasehaematology@ouh.nhs.uk

IRAS number

1010769